Tenaya appointed Eric Hyllengren as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer effective July 13, 2026, with Faraz Ali and Tomohiro Higa stepping down from their interim roles immediately prior.
| IndividualEric HyllengrenFaraz AliTomohiro Higa | RoleChief Financial Officer; Principal Financial Officer; Principal Accounting OfficerPresident and Chief Executive Officer; interim Principal Financial OfficerSenior Vice President, Finance; acting interim Principal Accounting Officer | Type of ChangeAppointedCeased interim roleCeased acting interim role | Effective DateJuly 13, 2026Immediately prior to July 13, 2026Immediately prior to July 13, 2026 | ReasonHiring to serve as CFO and principal financial/accounting officerReplaced as interim Principal Financial Officer upon Hyllengren's commencementReplaced as acting interim Principal Accounting Officer upon Hyllengren's commencement | Replacement InfoReplaces interim principal financial/accounting officers (Ali and Higa)Replaced by Eric HyllengrenReplaced by Eric Hyllengren | Background DetailsAge 51; recently CFO at Zura Bio Ltd. (Jul 2025–Apr 2026); prior roles at Atara Biotherapeutics (VP Finance & IR; CFO & COO) and Amgen; B.B.A. Notre Dame; MBA Kellogg (Northwestern)Not disclosedNot disclosed | Board/Committee Role ChangesNot disclosedNot disclosedNot disclosed |
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.